У нас вы можете посмотреть бесплатно 113. Cervical Intraepithelial Neoplasia (CIN) – Part 1 | USMLE Step 2 CK или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
📌𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗧𝗲𝗹𝗲𝗴𝗿𝗮𝗺 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 𝗛𝗲𝗿𝗲:- https://t.me/conceptualmedicine 📌 𝐅𝐨𝐥𝐥𝐨𝐰 𝐨𝐧 𝐈𝐧𝐬𝐭𝐚𝐠𝐫𝐚𝐦:- https://www.instagram.com/conceptual_... Cervical Intraepithelial Neoplasia (CIN) – Part 1 | USMLE Step 2 CK | HPV Pathogenesis, CIN1–3, LSIL/HSIL, Screening In this high-yield first installment on Cervical Intraepithelial Neoplasia (CIN), we build the foundation you need for USMLE Step 2 CK and U.S. clinical practice. We start with the transformation zone at the squamocolumnar junction—where metaplastic squamous epithelium is uniquely vulnerable to high-risk HPV (16, 18, 31, 33, 45). You’ll see how viral E6 (p53) and E7 (Rb) oncoproteins drive dysregulated cell cycling, setting up the histologic spectrum from CIN1 (lower third), CIN2 (up to two-thirds), to CIN3 (full-thickness). We translate pathology into the language of screening reports: LSIL corresponds mostly to CIN1, while HSIL corresponds to CIN2/3. Natural history is exam-favorite: CIN1 often regresses, CIN2 can regress in young patients but merits colposcopic evaluation, and CIN3 has the highest progression risk toward invasive cancer if untreated. Risk modifiers (tobacco, immunosuppression, early sexual debut, multiple partners) and HPV vaccination (9-valent) are framed as prevention with real-world impact. We then connect mechanism to modern screening and triage. You’ll master when to use primary HPV testing, co-testing, or cytology alone based on age, and how risk-based management steers next steps (repeat testing intervals, colposcopy, or expedited treatment in select high-risk results such as HPV16-positive HSIL). We explain colposcopic principles—acetic acid/iodine application, lesion grading, targeted biopsy, and the role of endocervical sampling—and preview tissue-sparing vs definitive options to be expanded in Part 2 (e.g., observation for select CIN1, excisional therapy for HSIL/CIN2–3). Practical pearls emphasize counseling on fertility implications, STI testing, smoking cessation, and adherence to follow-up. By the end of Part 1, you’ll have a crisp, mechanistic map—from HPV entry at the transformation zone to the histology-cytology vocabulary and initial risk-stratified pathways—that converts cervical dysplasia from memorization into pattern recognition for Western practice and the exam. #CIN #CervicalDysplasia #USMLEStep2CK #HPV #LSIL #HSIL #CIN1 #CIN2 #CIN3 #Colposcopy #PapSmear #HPVTesting #ASCCP #WomensHealth #Gynecology #GynecologicOncology #USMLEPreparation #MedicalEducationUSA #Step2CKPrep #CancerPrevention #ConceptualMedicine #MedicalConcepts #NEETPGPrep #FMGE2025 #USMLE2025 #ClinicalMedicine #MBBSConcepts #NextExamPrep #MedSchoolMadeEasy #MedStudentLife #HighYieldMedicine #PathophysiologySimplified #LearnMedicineFast #VisualMedicine #MedicalMnemonics #CrackNEETPG #USMLEStep1Prep #MedEducationRevolution #MBBSShorts #DoctorInTheMaking